We are live on
!
Find out more
NAMI
Nomura Asset Management International Portfolio holdings
AUM
$66.6B
This Fund
S&P 500
This Quarter
Est. Return
+24.24%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$66.6B
AUM Growth
+$8.21B
(+14%)
Cap. Flow
-$1.23B
Cap. Flow
% of AUM
-1.84%
Top 10 Holdings %
Top 10 Hldgs %
21.73%
Holding
1,429
New
172
Increased
379
Reduced
546
Closed
103
Avg Time Held
1.6
quarters
Top 10 Avg Time Held
1.4
quarters
Top 20 Avg Time Held
1.5
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$501M |
| 2 |
Apple
AAPL
|
+$428M |
| 3 |
Eli Lilly
LLY
|
+$390M |
| 4 |
Vanguard Russell 1000 Growth ETF
VONG
|
+$208M |
| 5 |
SPCX
SpaceX
SPCX
|
+$184M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Seagate
STX
|
+$1.37B |
| 2 |
Micron Technology
MU
|
+$414M |
| 3 |
Semtech
SMTC
|
+$199M |
| 4 |
Meta Platforms (Facebook)
META
|
+$175M |
| 5 |
Intuit
INTU
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.38% |
| 2 | Financials | 12.87% |
| 3 | Industrials | 12.33% |
| 4 | Healthcare | 10.94% |
| 5 | Consumer Discretionary | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1051
Dr. Reddy's Laboratories
RDY
$10.3B
| $1.97M | ﹤0.01% |
136,250
+55,282
| +68% | +$746K |
2025 Q4
2 quarters
|
|
1052
Emcor
EME
$34.4B
| $1.97M | ﹤0.01% |
2,372
-981
| -29% | -$830K |
2025 Q4
2 quarters
|
|
1053
Qorvo
QRVO
$10.1B
| $1.97M | ﹤0.01% |
21,100
| – | – |
2026 Q1
1 quarter
|
|
1054
MacroGenics
MGNX
$240M
| $1.94M | ﹤0.01% |
420,000
| – | – |
2025 Q4
2 quarters
|
|
1055
InvenTrust Properties
IVT
$2.32B
| $1.92M | ﹤0.01% |
54,355
+1,018
| +2% | +$33.4K |
2025 Q4
2 quarters
|
|
1056
NWPX Infrastructure Inc
NWPX
$1.02B
| $1.91M | ﹤0.01% |
12,764
| – | – |
2025 Q4
2 quarters
|
|
1057
Infosys
INFY
$43.6B
| $1.91M | ﹤0.01% |
182,120
-416,461
| -70% | -$5.22M |
2025 Q4
2 quarters
|
|
|
TRAX
1058
First Tracks Biotherapeutics
TRAX
$1.18B
| $1.89M | ﹤0.01% |
+93,732
| New | +$1.75M |
2026 Q2
0 quarters
|
|
1059
Procept Biorobotics
PRCT
$1.02B
| $1.85M | ﹤0.01% |
+82,153
| New | +$2.06M |
2026 Q2
0 quarters
|
|
1060
Organon & Co
OGN
$3.6B
| $1.85M | ﹤0.01% |
136,800
| – | – |
2025 Q4
2 quarters
|
|
1061
Victory Capital Holdings
VCTR
$7.09B
| $1.85M | ﹤0.01% |
22,000
-5,600
| -20% | -$451K |
2025 Q4
2 quarters
|
|
1062
OFG Bancorp
OFG
$2.15B
| $1.84M | ﹤0.01% |
37,600
| – | – |
2025 Q4
2 quarters
|
|
|
GAP
1063
The Gap Inc
GAP
$8.18B
| $1.84M | ﹤0.01% |
98,600
| – | – |
2025 Q4
2 quarters
|
|
1064
Elastic
ESTC
$9.96B
| $1.8M | ﹤0.01% |
+31,663
| New | +$1.7M |
2026 Q2
0 quarters
|
|
1065
Adobe
ADBE
$94.9B
| $1.8M | ﹤0.01% |
8,773
-11,450
| -57% | -$2.71M |
2025 Q4
2 quarters
|
|
1066
Telkom Indonesia
TLK
$12.7B
| $1.79M | ﹤0.01% |
+133,422
| New | +$2.22M |
2026 Q2
0 quarters
|
|
1067
Regenxbio
RGNX
$512M
| $1.78M | ﹤0.01% |
149,000
| – | – |
2025 Q4
2 quarters
|
|
1068
Enterprise Products Partners
EPD
$79.5B
| $1.78M | ﹤0.01% |
48,380
-6,260
| -11% | -$236K |
2025 Q4
2 quarters
|
|
|
KARD
1069
Kardigan Inc
KARD
$1.42B
| $1.77M | ﹤0.01% |
+74,233
| New | +$1.72M |
2026 Q2
0 quarters
|
|
1070
Highwoods Properties
HIW
$3.25B
| $1.77M | ﹤0.01% |
58,591
-531
| -0.9% | -$13.7K |
2025 Q4
2 quarters
|
|
1071
Super Micro Computer
SMCI
$28.4B
| $1.73M | ﹤0.01% |
+59,001
| New | +$1.88M |
2026 Q2
0 quarters
|
|
1072
PVH
PVH
$3.46B
| $1.72M | ﹤0.01% |
23,100
| – | – |
2025 Q4
2 quarters
|
|
1073
Kymera Therapeutics
KYMR
$9.13B
| $1.71M | ﹤0.01% |
+14,925
| New | +$1.28M |
2026 Q2
0 quarters
|
|
1074
Saic
SAIC
$5.32B
| $1.71M | ﹤0.01% |
15,500
| – | – |
2026 Q1
1 quarter
|
|
|
AAT
1075
American Assets Trust
AAT
$1.31B
| $1.7M | ﹤0.01% |
68,800
| – | – |
2025 Q4
2 quarters
|
|
Similar funds
Nomura Asset Management International's Q2 2026 Portfolio in Review
As of Q2 2026, Nomura Asset Management International held 1,429 positions worth $66.6B, up 14% from $58.4B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Nomura Asset Management International's Q2 2026 filing shows 172 new, 379 increased, 546 reduced and 103 closed positions. Its largest new stake was Vanguard Russell 1000 Growth ETF: 1,674,624 shares worth $214M. The largest sale was Seagate, an estimated $1.37B.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 26% a quarter earlier, followed by Financials and Industrials.
- Nomura Asset Management International's largest Q2 2026 buy was Vanguard Russell 1000 Growth ETF: 1,674,624 shares worth $214M.
- Nomura Asset Management International added most to Lam Research in Q2 2026, an estimated $501M increase.
- Nomura Asset Management International's biggest Q2 2026 reduction was Seagate, cutting an estimated $1.37B.
- Nomura Asset Management International fully exited Ascendis Pharma A/S in Q2 2026, selling an estimated $127M.
- Nomura Asset Management International's ten largest holdings make up 22% of its $66.6B portfolio in Q2 2026.
- Nomura Asset Management International opened 172 new positions and closed 103 in Q2 2026.
- Nomura Asset Management International's portfolio value rose 14% quarter-over-quarter to $66.6B.
Based on Nomura Asset Management International's 13F filing for Q2 2026, filed 14 Aug 2026.